India: Daily Stock Market Performance Insight - May 12, 2026

The Indian equity market witnessed a severe broad-based sell-off on May 12, 2026, with the Sensex plunging 1,456.04 points or 1.92 percent to close at 74,559.24. The Nifty50 mirrored this weakness, shedding 436.30 points or 1.83 percent to finish at 23,379.55. Negative sentiment permeated the entire floor as the Nifty Midcap 100 declined 2.54 percent and the Smallcap 100 slipped 3.17 percent. All sectoral indices ended in the red, with Nifty Realty, IT, and Consumer Durables emerging as the worst performers during the session.

A combination of macroeconomic headwinds triggered this aggressive correction. The Indian Rupee hit a record closing low of 95.63 against the US dollar, depreciating by 79 paise from its previous close. Simultaneously, global energy concerns intensified as Brent crude prices surged nearly 4 percent to 105.7 dollars per barrel, while WTI crude rose 3.23 percent to 101.24 dollars. This pressure was compounded by massive institutional selling, as Foreign Institutional Investors recorded a net outflow of 8,437.56 crore rupees on May 11, significantly dampening domestic liquidity.

Earnings results showed stark divergence, providing mixed cues for individual stock pickers. Route Mobile reported a stellar 93.2 percent surge in Q4 FY26 net profit, and Indoco Remedies saw 21.89 percent sales growth despite a narrowing loss. Conversely, Dixon Technologies struggled with a 36 percent fall in net profit. In the energy space, ONGC provided a rare bright spot, rallying 6 percent after a government cut in crude and gas royalty rates, which analysts suggest could enhance the company fair value by 7 to 9 percent.

Looking ahead, while pharmaceutical giants Cipla and Zydus Life Sciences are expanding global footprints with new US launches like Miraaban, the short-term market outlook remains cautious. Investors should monitor the Rupee and crude price nexus for stabilization before increasing equity exposure. Current brokerage recommendations include buy calls for Max Healthcare Institute with a target of 1100 rupees and Coal India with a target of 500 rupees, though institutional exits continue to weigh on general sentiment.